Skip to main content
Medical information Clinical review pending

Genetic Testing

IDS Gene Mucopolysaccharidosis Type 2 Genetic Test

Genetic test using Next-Generation Sequencing (NGS) to identify mutations in the IDS gene associated with Mucopolysaccharidosis Type 2 (MPS II), a rare metabolic disorder. Aids in early diagnosis and management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (usually collected in an EDTA tube) or saliva sample. Confirm specific requirements with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No special preparation is typically required for a blood or saliva sample. However, discuss any specific instructions with your healthcare provider or the laboratory.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the IDS Gene Mucopolysaccharidosis Type 2 Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals with symptoms suggestive of Mucopolysaccharidosis Type 2 (MPS II)
  • ✓Family history of MPS II
  • ✓Genetic counseling for hereditary metabolic disorders
  • ✓Confirmation of diagnosis
  • ✓Carrier screening in families with known MPS II mutations
02

In plain language

What this test helps you understand

This test helps confirm or rule out a diagnosis of Mucopolysaccharidosis Type 2 (MPS II) by identifying mutations in the IDS gene. It aids in understanding the genetic basis of the condition, guiding treatment decisions, and providing information for genetic counseling and family planning.
The IDS Gene Mucopolysaccharidosis Type 2 NGS Genetic DNA Test is a diagnostic tool used to detect mutations in the IDS gene. These mutations cause Mucopolysaccharidosis Type 2 (MPS II), also known as Hunter syndrome, a rare inherited metabolic disorder. This test uses advanced Next-Generation Sequencing (NGS) technology for accurate detection of genetic changes.

This test identifies specific mutations in the IDS gene, which result in a deficiency of the iduronate-2-sulfatase enzyme. This enzyme deficiency leads to the buildup of complex sugars called glycosaminoglycans (GAGs) in various body tissues, potentially causing a range of health problems. Identifying these genetic mutations helps healthcare providers understand the condition and guide appropriate management strategies.

This test is recommended for individuals with symptoms suggestive of MPS II, a family history of the disorder, or those seeking genetic counseling for hereditary conditions. Early diagnosis is crucial for initiating timely interventions and improving health outcomes. Understanding the genetic basis of the condition can also inform family planning and access to specialized care.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is typically required for a blood or saliva sample. However, discuss any specific instructions with your healthcare provider or the laboratory.
SampleBlood sample (usually collected in an EDTA tube) or saliva sample. Confirm specific requirements with the laboratory before booking.
MethodologyNext-Generation Sequencing (NGS) of the IDS gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects mutations within the IDS gene. It may not detect all possible mutations, such as large deletions or duplications, depending on the specific methodology used. A negative result does not completely rule out MPS II if clinical suspicion is high. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

MPS II, also known as Hunter syndrome, is a rare, inherited metabolic disorder caused by a deficiency of the iduronate-2-sulfatase enzyme, leading to the buildup of complex sugars in the body.
This test detects specific mutations in the IDS gene, which are responsible for causing MPS II.
Individuals with symptoms of MPS II, a family history of the disorder, or those recommended by their doctor or genetic counselor should consider this test.
A sample is typically collected via a blood draw or a saliva sample. Please confirm the exact requirements with the laboratory.
Confirm with the laboratory before booking.
Your doctor or genetic counselor will discuss the results with you, explain their meaning, and recommend appropriate next steps, which may include further testing or management strategies.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp